Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RIGL
DateTimeSourceHeadlineSymbolCompany
13/01/202513:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
13/01/202513:05PR Newswire (US)Rigel Provides Business Update and 2025 OutlookNASDAQ:RIGLRigel Pharmaceuticals Inc
09/01/202513:05PR Newswire (US)Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDSNASDAQ:RIGLRigel Pharmaceuticals Inc
08/01/202513:05PR Newswire (US)Rigel to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/202513:05PR Newswire (US)Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
09/12/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
09/12/202417:02PR Newswire (US)Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and ExpositionNASDAQ:RIGLRigel Pharmaceuticals Inc
02/12/202413:05PR Newswire (US)Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDSNASDAQ:RIGLRigel Pharmaceuticals Inc
27/11/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
27/11/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
27/11/202401:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
14/11/202422:18Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
14/11/202420:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
12/11/202413:05PR Newswire (US)Rigel to Present at the Jefferies London Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202421:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RIGLRigel Pharmaceuticals Inc
07/11/202421:01PR Newswire (US)Rigel Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
05/11/202414:05PR Newswire (US)Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and ExpositionNASDAQ:RIGLRigel Pharmaceuticals Inc
31/10/202412:05PR Newswire (US)Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
24/10/202420:35PR Newswire (US)Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)NASDAQ:RIGLRigel Pharmaceuticals Inc
16/10/202414:00GlobeNewswire Inc.Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®NASDAQ:RIGLRigel Pharmaceuticals Inc
04/10/202412:05PR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
19/09/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
12/09/202412:05PR Newswire (US)Rigel to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:RIGLRigel Pharmaceuticals Inc
05/09/202411:30PR Newswire (US)Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AMLNASDAQ:RIGLRigel Pharmaceuticals Inc
05/09/202400:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
05/09/202400:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
03/09/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
03/09/202412:00PR Newswire (US)Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and TaiwanNASDAQ:RIGLRigel Pharmaceuticals Inc
29/08/202412:05PR Newswire (US)Rigel to Participate in Upcoming September Investor ConferencesNASDAQ:RIGLRigel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RIGL